It is known that virtually all WD and DD liposarcomas have MDM2 amplification and close to 90% have CDK4 amplification and this is felt to be an early event in the pathogenesis of these tumors [1, 11, 12]. This evidence concerns the gene MDM2 and liposarcoma.